Leading Manufacturer and Supplier of Diethylcarbamazine 50mg Tablets (Ezula) PAN India
Taj Pharma India is a globally recognized Diethylcarbamazine Tablets (Ezula) manufacturer, supplier, and exporter, headquartered in Vapi, Gujarat. We are dedicated to delivering premium-quality Diethylcarbamazine 50mg Tablets to meet the growing demands of healthcare providers, distributors, and government programs across India and international markets. Our production facilities are WHO-GMP certified, ensuring strict quality standards, safety, and efficacy in every batch.
Overview of Diethylcarbamazine 50mg Tablets (Ezula)
Diethylcarbamazine (Ezula) Tablets 50mg belong to the anthelmintic class of medications, prescribed for the treatment of filariasis, schistosomiasis, intestinal and hepatic amoebiasis, liver abscesses, diarrhea, periodontitis, and other parasitic worm infections. The tablets work by eliminating microfilariae and parasitic worms, ensuring effective treatment of parasitic infections and promoting rapid patient recovery.
Our Manufacturing Excellence
At Taj Pharma India, we operate state-of-the-art production units in Vapi, Gujarat, with advanced quality control and analytical labs to maintain unparalleled purity and consistency. Our manufacturing process strictly adheres to WHO-GMP and ISO standards, providing assurance of global compliance and therapeutic reliability.
Key Features of Our Manufacturing Process:
- High-grade raw material sourcing from trusted suppliers.
- Stringent quality testing at each production stage.
- Precision in tablet formulation to ensure uniform potency.
- Advanced packaging to maintain shelf life and drug stability.
Therapeutic Indications of Diethylcarbamazine Tablets
Diethylcarbamazine 50mg Tablets are primarily indicated for:
- Filariasis (lymphatic and subcutaneous forms)
- Schistosoma infections
- Intestinal amoebiasis
- Hepatic amoebiasis
- Liver abscesses
- Diarrhea caused by parasitic worms
- Periodontitis and other oral infections
The medication helps control the spread of parasitic infections and is often included in national public health programs for mass filariasis eradication.
Dosage and Administration
- Strength: 50mg per tablet
- Route: Oral administration
- Usage: Taken with food to minimize gastrointestinal discomfort
- Treatment Duration: As prescribed by the physician, based on infection severity
Medical Guidelines:
- Complete the full course of treatment to prevent reinfection.
- Regular monitoring of liver function and blood counts is recommended during therapy.
- Patients should report allergic reactions or unusual symptoms promptly.
Global Supply and Distribution
Taj Pharma India is a PAN India supplier and international exporter of Diethylcarbamazine Tablets, with an extensive reach:
- Africa: Nigeria, Kenya, Ghana, South Africa, Tanzania
- Middle East: UAE, Saudi Arabia, Oman, Iraq
- LATAM: Brazil, Mexico, Argentina, Peru
- Asia-Pacific: Sri Lanka, Myanmar, Philippines, Vietnam
We provide bulk supply solutions to hospitals, clinics, and government agencies, supporting large-scale healthcare initiatives.
PCD Pharma Franchise and Third-Party Manufacturing
We offer PCD Pharma Franchise opportunities for Diethylcarbamazine Tablets (Ezula), enabling partners to grow their market presence with our high-quality products. Our third-party manufacturing services allow pharma companies to market Diethylcarbamazine Tablets under their own brand names, backed by Taj Pharma’s quality assurance.
Benefits of Partnering with Taj Pharma:
- WHO-GMP certified production ensuring high-quality medicines.
- Competitive pricing for bulk orders and franchise partners.
- Reliable logistics and timely delivery across India and international markets.
- Dedicated technical and marketing support for partners.
Technical Specifications
- Generic Name: Diethylcarbamazine
- Brand Name: Ezula
- Strength: 50mg
- Dosage Form: Oral Tablets
- Route of Administration: Oral, with meals
- Packaging: Blister/strip packs and bulk cartons for export
- Storage: Store in a cool, dry place away from direct sunlight
- Regulatory Compliance: WHO, ISO, and national health authority-approved
Quality Assurance and Safety
At Taj Pharma India, quality is our priority. Every batch of Diethylcarbamazine Tablets undergoes rigorous quality checks, including:
- Potency and uniformity testing
- Microbial and contaminant analysis
- Stability studies for shelf-life validation
Patients and healthcare providers can trust Taj Pharma’s Diethylcarbamazine Tablets for safe, reliable, and effective treatment.
Why Taj Pharma India Stands Out
- Top-rated Diethylcarbamazine Tablets manufacturer and supplier in India.
- Extensive global distribution network across multiple continents.
- Affordable pricing without compromising quality.
- Support for healthcare programs and government tenders.
- PCD Pharma Franchise and third-party manufacturing for business expansion.
Taj Pharma India continues to lead the pharmaceutical market by providing high-quality, effective, and globally compliant Diethylcarbamazine Tablets, ensuring better health outcomes for patients worldwide.
